Global Vascular Grafts Market Size study, by Product (Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts), By Raw Material (Synthetic Vascular Grafts, Biolog

Global Vascular Grafts Market Size study, by Product (Hemodialysis Access Grafts, Endovascular Stent Grafts, Coronary Artery By-Pass Grafts, Vascular Grafts for Aorta Disease, Peripheral Vascular Grafts), By Raw Material (Synthetic Vascular Grafts, Biological Vascular Grafts, Hybrid Vascular Grafts), By Application (Cardiac Aneurysm, Kidney Failure, Vascular Occlusion, Coronary Artery Disease) and Regional Forecasts 2022-2032

Global Vascular Grafts Market is valued at approximately USD 1.7 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.20% over the forecast period 2024-2032. Vascular grafts are medical devices used in vascular surgery to replace or bypass damaged or diseased blood vessels. They are essentially artificial blood vessels that are surgically implanted to restore blood flow in cases where natural blood vessels are blocked, narrowed, or weakened. Vascular grafts are made from various materials such as synthetic polymers (e.g., polyethylene terephthalate or Dacron), biological tissues (e.g., human, or animal-derived), or a combination of both. These grafts are used in a variety of vascular procedures, including coronary artery bypass grafting (CABG), peripheral artery bypass surgery, arteriovenous (AV) access for dialysis, and repair of aneurysms. Vascular grafts help in treating cardiovascular diseases, peripheral vascular diseases, and other conditions that affect blood circulation. The increasing adoption of minimally invasive procedures for vascular surgeries is a key trend for the Global Vascular Grafts Market as it offer advantages such as reduced recovery time, lower risk of complications, and improved patient outcomes.

In addition, the expansion of the Vascular Grafts Market is predominantly fueled by the surge in demand for vascular access for hemodialysis and the escalating geriatric population. Also, the increasing prevalence of cardiovascular diseases are associated to lifestyle factors such as diabetes and hypertension, has led to a growing demand for vascular grafts used in critical procedures such as bypass surgeries. Also, rising technological advancements play a crucial role, with innovations in graft materials, such as bioengineered options and more durable synthetics, enhancing the efficacy and durability of vascular grafts and driving their adoption. Moreover, its compatibility with aortic cross-clamp and cardiopulmonary bypass systems adds to its attractiveness. Additionally, the progress in surgical methodologies, particularly those incorporating coronary artery stent-grafts, is poised to boost the need for vascular grafts in the foreseeable future. The extensive adoption of prosthetic grafts such as electrospun polyurethane vascular grafts for addressing intricate vascular trauma, attributed to their capacity to lower the risk of neointimal formation, is expected to drive market expansion consistently across the projected period of 2024-2032. Furthermore, the trend towards minimally invasive surgeries has surged, boosting the demand for vascular grafts used in such procedures due to their reduced recovery times and fewer complications, which are further presenting various growth prospects to the Global Vascular Grafts Market during the estimated period. However, risk associated with graft failures, coupled with the high cost of vascular graft procedures is expected to stifle Global Vascular Grafts Market growth between 2022 and 2032.

The key regions considered for the global Vascular Grafts Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominates the Vascular Grafts Market share because of rising prevalence rates of diabetes, cardiovascular diseases, and chronic kidney disease in the region. According to the Centers for Disease Control and Prevention, in the United States, heart disease stands as the primary cause of death among men, women, and individuals across various racial and ethnic backgrounds. The region has one cardiovascular disease-related death every 33 seconds. Along with heart disease claimed the lives of almost 695,000 persons in 2021, accounting for 1 in 5 fatalities. Additionally, the market's growth is further propelled by robust reimbursement coverage and advanced healthcare infrastructure available in North America. Whereas, Asia Pacific is poised for rapid growth over the forecast period of 2024-2032 driven by increasing incidence of kidney disorders and increasing government spending.


Major market player included in this report are:
Medtronic Plc
Terumo Corporation
LeMaitre Vascular, Inc.
Getinge AB
Becton, Dickinson and Company
Abbott Laboratories
B. Braun Melsungen AG
W. L. Gore & Associates, Inc.
MicroPort Scientific Corporation
Endologix, Inc.

The detailed segments and sub-segment of the market are explained below:

By Product
Hemodialysis Access Grafts
Endovascular Stent Grafts
Coronary Artery By-Pass Grafts
Vascular Grafts for Aorta Disease
Peripheral Vascular Grafts

By Raw Material
Synthetic Vascular Grafts
Biological Vascular Grafts
Hybrid Vascular Grafts

By Application
Cardiac Aneurysm
Kidney Failure
Vascular Occlusion
Coronary Artery Disease

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.